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Generalized joint hypermobility: a timely population
study and proposal for Beighton cut-offs
Beighton cut-offs for generalized joint hypermobility
5
This commentary refers to Beighton scores and cut-
offs across the lifespan: cross-sectional study of an
Australian population, Harjodh Singh et al.
Interest in joint hypermobility within the performing arts,
10 sports and medical communities has increased over the
past 10 years, and this is reflected by the exponential
growth in the number of publications in peer-reviewed
journals over the past decade. Controversy exists over
cut-off limits for generalized joint hypermobility (GJH)
15 and whether or not GJH is a risk factor for injury.
However, there is a growing evidence base for an asso-
ciation between GJH and musculoskeletal pain, fatigue
and disability [1]. Furthermore, readers will be aware
that joint laxity is also a feature of several of the hereditary
20 disorders of connective tissue, such as Ehlers!Danlos
Syndromes, Marfan Syndrome and Osteogenesis
Imperfecta. The Beighton scale forms part of the diagnos-
tic criteria for some of these syndromes. Therefore, an
accurate method for identifying joint hypermobility
25 across the lifespan, in different ethnic groups and in
both males and females, is required in order to make an
accurate diagnosis. The population study published in this
issueAQ2 of Rheumatology entitled ‘Beighton scores and cut-
offs across the lifespan: cross-sectional study of an
30 Australian population’ [2] is timely, and provides readers
with a well-reasoned argument for proposed gender-
specific cut-offs across the lifespan.AQ3
First developed in 1973 as an adaption of the Carter
WilkinsAQ4 scale, the 9-point Beighton scale was designed
35 as an epidemiological tool for identifying generalized
hypermobility in Africa [3]. It was initially intended for
adults and was not intended to be used for assessing
children or in a clinical context. Other more comprehen-
sive hypermobility scoring systems have been devised,
40 such as the Rote`s-Que´rol scale [4], Bulbena scale [5],
Contompasis score [6] and the Lower Limb Assessment
Scale [7]. However, the Beighton scale, which is time-ef-
ficient and easy to administer, is the most commonly
used. Limitations of the Beighton scale include the binary
45 all-or-nothing scoring system, upper limb focus and single
plane joint motion assessment. However, despite these
limitations, the Beighton scale demonstrates good con-
tent validity in paediatric populations and high inter-exam-
iner reproducibility at all ages [8!10]. The original Beighton
50 scale used an arbitrary cut-off of four or more joints to
determine GJH. Cut-offs of five, six, seven and even
eight have been used in younger populations as a way
of accounting for flexibility in youth.
The authors of the current study critically justify the
55case for using Beighton score cut-offs closest to
the uppermost 5%, which correlates to 2 S.D. above the
mean. This thinking is in line with the 1965 recommenda-
tion of the American Academy of Orthopaedic Surgeons
seeking to prevent overdiagnosis of joint hypermobility
60and to allow for the greatest accuracy in determining vari-
ations from the normal range of movement across age-
groups and genders. Using this new criterion, a portrait of
GJH in a typical Australian population is presented.
The paper concludes with an interesting recommenda-
65tion by the authors of using a second assessment of joint
mobility, such as the Lower limb Assessment Scale, which
examines multidimensional joint and tissue movement in
order to improve the validity of a diagnosis. This would be
aimed at children, as that measure has not yet been vali-
70dated in adults. In conclusion, this is an important article
that provides researchers and clinicians with a new ap-
proach to assessing and determining GJH across the
lifespan.
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